期刊文献+

(E)-5-(2,5-二甲基-4-(丙烯基)苯氧基)-2,2-二甲基戊酸的合成

Synthesis of (E)-5-(2,5-Dimethyl-4-(prop-1-enyl)phenoxy)-2,2-dimethylpentanoic Acid
下载PDF
导出
摘要 以吉非罗齐、丙酰氯为起始原料,经付克酰化、还原、脱水三步反应制得了(E)-5-(2,5-二甲基-4-(丙烯基)苯氧基)-2,2-二甲基戊酸,总收率31.8%,目标化合物经1HNMR和13CNMR确证结构。该工艺所用反应试剂和原料价廉易得,操作简便。 With gemfibrozil and propionyl chloride as starting material,(E)-5-(2,5-dimethyl-4-(prop-1-enyl)phenoxy)-2,2-dimethylpentanoic acid,an impurity of gemfibrozil,was synthesized by three-step reactions including acylation,reduction and dehydration.The total yield was 31.8%.The objective compound synthesized had been characterized by 1HNMR and 13CNMR.This improved procedure had several advantages of low consumption,mild condition,convenient operation.
出处 《化学与生物工程》 CAS 2010年第11期20-22,共3页 Chemistry & Bioengineering
关键词 吉非罗齐 (E)-5-(2 5-二甲基-4-(丙烯基)苯氧基)-2 2-二甲基戊酸 合成 gemfibrozil (E)-5-(2 5-dimethyl-4-(prop-1-enyl)phenoxy)-2 2-dimethylpentanoic acid synthesis
  • 相关文献

参考文献8

  • 1Frick M H, Elo O, Haapa K, et al. Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease[J]. N Engl J Med, 1987, 317 (20) : 1237-1245.
  • 2狄树亭,王立江,曹登瑞.吉非罗齐降脂疗效的临床观察[J].中国煤炭工业医学杂志,2002,5(10):1066-1066. 被引量:1
  • 3芦金荣,马英.吉非罗齐的合成[J].中国现代应用药学,2000,17(2):124-125. 被引量:1
  • 4丁素文,刘学和,刘丽丽.吉非罗齐合成工艺的研究[J].黑龙江医药,1997,10(6):338-339. 被引量:1
  • 5Abraham D J, Kennedy P E, Mehanna A S, et al. Design, synthesis, and testing of potential antisickling agents. 4. Structureactivity relationships of henzyloxy and phenoxy acids[J]. J Med Chem, 1984,27(8) :967-978.
  • 6Kearney F R. Process for preparing 5-(2,5-dimethylphenoxy)-2, 2-dimethylpentanoic acid[P]. USP 4 665 226,1987-05-12.
  • 7王晓伟.吉非罗齐合成路线图解[J].中国医药工业杂志,1990,21(4):188-189. 被引量:3
  • 8Kabbash Christina, Sitverstein Samuel C, Shuman Howard A, et al. Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof[P]. USP 6 531 291, 2003- 11-19.

二级参考文献9

  • 11,Gemfibrozil.USPⅩⅩⅡ,1990∶602.
  • 22,Jose RS,Jose Ignacio BB,Eugenio FG.Process for the preparation ofgemfibrozil.Span,1986∶549470(CA 1987,106:66916s).
  • 33,Jose Ignacio BB,Jose RS,Eugenio FG.Process for the preparation ofgemfibrozil.Span,1986∶549469(CA 1987,106:66899p).
  • 44,Kearney FR.Process for preparing 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid asan agent for treatment or prevention of arteriosclerosis.US,1987∶4665226(CA1987,107:39419w).
  • 55,CregerPL.2,2-dimethyl-ω-aryloxyalkanoicacids,theirsaltsandesters.GerOffen,1969∶1925423(CA1970,72:43167p).
  • 66,Augstein J,Austin WC,Boscott RJ,et al.Some cardioveascular effects of a series ofaryloxyalkylamines.J Med Chem,1965,8(3)∶356.
  • 7杜国有.糖尿病和心脑血管病患者脂质及载脂蛋白水平分析[J].临床荟萃,2000,15(15):697-698. 被引量:24
  • 8孟立辉,蒋忠武,柳金明,李丽萍.脑血管性疾病血流变指标及血脂谱的测定分析[J].中国血液流变学杂志,2000,10(3):178-181. 被引量:28
  • 9常永超,杨旭明,简雪峰,许德英.高脂血症患者的血液流变学改变[J].临床荟萃,2002,17(2):102-103. 被引量:16

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部